Data Sheet 1_Checkpoint based immunotherapy in non-small cell lung cancer: a real-world retrospective study.docx

Data Sheet 1_Checkpoint based immunotherapy in non-small cell lung cancer: a real-world retrospective study.docx

Introduction<p>Immune checkpoint inhibitor (ICI)-based immunotherapy targeting programmed cell death 1 (PD-1) or its ligand 1 (PD-L1) has radically changed the management of many types of solid tumors including non-small cell lung cancer (NSCLC). Many clinical trials have demonstrated that ICI...

Full description

Saved in:
Bibliographic Details
Main Author: Luigi Liguori (9434405) (author)
Other Authors: Gabriele Giorgio (20344950) (author), Giovanna Polcaro (9434414) (author), Valentina Pagliara (833658) (author), Domenico Malandrino (20344953) (author), Francesco Perri (10489823) (author), Marco Cascella (4162600) (author), Alessandro Ottaiano (7213883) (author), Valeria Conti (450156) (author), Alberto Servetto (7063877) (author), Roberto Bianco (579881) (author), Stefano Pepe (2530405) (author), Francesco Sabbatino (3777304) (author)
Published: 2024
Subjects:
Genetic Immunology
biomarker
ICI
immunotherapy
NSCLC
PD-1
PD-L1
predictive
real-world
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items